Related Experiment Videos
Practical management of treatment-resistant depression
1Department of Psychiatry, Pennsylvania State University College of Medicine, Hershey, USA.
American Family Physician
|December 23, 1998
Summary
Many patients show antidepressant resistance. Optimizing dosage or duration is key for partial responders, while substitution suits nonresponders. Combination therapy is generally discouraged.
Area of Science:
- Psychiatry
- Pharmacology
Background:
- Antidepressant monotherapy is ineffective in 10-30% of patients.
- Treatment resistance poses a significant clinical challenge.
Purpose of the Study:
- To outline strategies for managing antidepressant treatment resistance.
- To guide clinicians in optimizing antidepressant therapy for non-responsive patients.
Main Methods:
- Review of clinical guidelines and evidence for managing treatment-resistant depression.
- Analysis of strategies including dosage optimization, drug substitution, combination therapy, and electroconvulsive therapy.
Main Results:
- Partial responders benefit from optimizing dosage or duration.
- Nonresponders may require antidepressant substitution.
- Combination therapy is generally not recommended due to risks.
- Electroconvulsive therapy is indicated for severe, refractory depression.
Conclusions:
- Sequential treatment strategies are recommended over combination therapy.
- Augmentation therapy with agents like lithium, thyroid hormone, pindolol, or buspirone can be effective for partial responders.